Mycoplasma genitalium presence, resistance and epidemiology in Greenland

Objectives . Greenland reports the highest rates of chlamydial infection and gonorrhea in the Arctic. Our objective was to determine the presence, and describe the basic epidemiology, of Mycoplasma genitalium for Greenland. Study design . Cross-sectional study. Methods . 314 residents from Nuuk and Sisimiut, between the ages of 15 and 65 years, participated in “Inuulluataarneq” (the Greenland Sexual Health Project) between July 2008 and November 2009. Participants provided self-collected samples for sexually transmitted infection (STI) testing and completed a sexual health survey. Descriptive statistics and logistic regression were used to summarize the basic characteristics of STI cases overall and M. genitalium and Chlamydia trachomatis specifically. Clinically relevant characteristics in each full model were gender (male or female), age (in years), age at sexual debut (in years), number of sexual partners in the past 3 months (continuous) and history of forced sex and community. Results . The overall prevalence of STIs was 19.0%, specifically: 9.8% for M. genitalium and 9.4% for C. trachomatis; 100% of M. genitalium-positive cases carried macrolide resistance determinants. Being female [OR = 3.2; 95% confidence interval (CI): 1.1–9.8] and younger age (OR = 0.9; 95% CI: 0.9–1.0) were associated with M. genitalium positivity. Age was also associated with C. trachomatis (OR = 0.9; 95% CI: 0.8–0.9) and STI positivity overall (OR = 0.9; 95% CI: 0.9–0.9). Conclusions . We observed a high prevalence of M. genitalium and macrolide resistance in this study. A better understanding of M. genitalium sequelae is needed to inform policy around testing, treatment, control and antibiotic use.

[1]  M. Unemo,et al.  Population‐based assessment of Mycoplasma genitalium in Vietnam – low prevalence among married women of reproductive age in a rural area , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[2]  J. Jensen,et al.  A serological study of the role of Mycoplasma genitalium in pelvic inflammatory disease and ectopic pregnancy , 2007, Sexually Transmitted Infections.

[3]  A. Meier,et al.  Mycoplasma genitalium Infection and Persistence in a Cohort of Female Sex Workers in Nairobi, Kenya , 2006, Sexually transmitted diseases.

[4]  L. Manhart.  Has the time come to systematically test for Mycoplasma genitalium? , 2009, Sexually transmitted diseases.

[5]  S. Kerry,et al.  Prevalence of Mycoplasma genitalium in early pregnancy and relationship between its presence and pregnancy outcome , 2004, BJOG : an international journal of obstetrics and gynaecology.

[6]  J. Wasserheit,et al.  The dynamic topology of sexually transmitted disease epidemics: implications for prevention strategies. , 1996, The Journal of infectious diseases.

[7]  J. Jensen,et al.  Mycoplasma genitalium as a sexually transmitted infection: implications for screening, testing, and treatment , 2006, Sexually Transmitted Infections.

[8]  C. Haggerty.  Evidence for a role of Mycoplasma genitalium in pelvic inflammatory disease , 2008, Current opinion in infectious diseases.

[9]  S. Birkelund,et al.  Mycoplasma genitalium, Chlamydia trachomatis, and tubal factor infertility--a prospective study. , 2008, Fertility and sterility.

[10]  M. Unemo,et al.  A fast real-time polymerase chain reaction method for sensitive and specific detection of the Neisseria gonorrhoeae porA pseudogene. , 2006, The Journal of molecular diagnostics : JMD.

[11]  U. Kasprzykowska,et al.  Occurrence of Mycoplasma genitalium in fertile and infertile women. , 2009, Fertility and sterility.

[12]  M. Alary,et al.  Mycoplasma genitalium: an organism commonly associated with cervicitis among west African sex workers , 2005, Sexually Transmitted Infections.

[13]  K. Holmes,et al.  Mycoplasma genitalium among young adults in the United States: an emerging sexually transmitted infection. , 2007, American journal of public health.

[14]  S. Tabrizi,et al.  Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  Sunil J Rao,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2003 .

[16]  J. Jensen,et al.  Mycoplasma genitalium: a common cause of persistent urethritis among men treated with doxycycline , 2006, Sexually Transmitted Infections.

[17]  M. Beksinska,et al.  Microbicide Applicators: Understanding Design Preferences Among Women in the Dominican Republic and South Africa , 2007, Sexually transmitted diseases.

[18]  K. Holmes,et al.  Comparative Epidemiology of Heterosexual Gonococcal and Chlamydial Networks: Implications for Transmission Patterns , 2000, Sexually transmitted diseases.

[19]  F. Veas,et al.  Trichomonas vaginalis: repeated DNA target for highly sensitive and specific polymerase chain reaction diagnosis. , 1994, Cellular and molecular biology.

[20]  Stuart Berman,et al.  Sexually transmitted diseases treatment guidelines, 2010. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[21]  M. Unemo,et al.  First evaluation of polymerase chain reaction assays used for diagnosis of Mycoplasma genitalium in Russia , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[22]  R. Kerani,et al.  Comprehensive Assessment of Sociodemographic and Behavioral Risk Factors for Mycoplasma genitalium Infection in Women , 2010, Sexually transmitted diseases.

[23]  A. Renton,et al.  Association of Mycoplasma genitalium with acute non-gonococcal urethritis in Russian men: a comparison with gonococcal and chlamydial urethritis , 2009, International journal of STD & AIDS.

[24]  F. Olesen,et al.  Mycoplasma genitalium: prevalence and behavioural risk factors in the general population , 2006, Sexually Transmitted Infections.

[25]  K. Thomas,et al.  Associations between Mycoplasma genitalium, Chlamydia trachomatis and pelvic inflammatory disease , 2003, Journal of clinical pathology.

[26]  G. Burstein,et al.  Sexually transmitted diseases treatment guidelines , 2003, Current opinion in pediatrics.

[27]  K. Holmes,et al.  Correlates of Cervical Mycoplasma genitalium and Risk of Preterm Birth Among Peruvian Women , 2010, Sexually transmitted diseases.

[28]  J. Jensen,et al.  Detection of Mycoplasma genitalium by PCR Amplification of the 16S rRNA Gene , 2003, Journal of Clinical Microbiology.

[29]  S. Aral.  Heterosexual transmission of HIV: the role of other sexually transmitted infections and behavior in its epidemiology prevention and control. , 1993, Annual review of public health.

[30]  C. Fairley,et al.  Persistence of Mycoplasma genitalium Following Azithromycin Therapy , 2008, PloS one.

[31]  E. Rink,et al.  Sexual Health and Sexually Transmitted Infections in the North American Arctic , 2008, Emerging infectious diseases.

[32]  D. Gesink,et al.  Developing a culturally competent and socially relevant sexual health survey with an urban arctic community , 2010, International journal of circumpolar health.

[33]  J. Jensen,et al.  Use of TaqMan 5′ Nuclease Real-Time PCR for Quantitative Detection of Mycoplasma genitalium DNA in Males with and without Urethritis Who Were Attendees at a Sexually Transmitted Disease Clinic , 2004, Journal of Clinical Microbiology.

[34]  J. Jensen,et al.  Mycoplasma genitalium: prevalence, clinical significance, and transmission , 2005, Sexually Transmitted Infections.

[35]  J. Jensen,et al.  Prevalence of Mycoplasma genitalium among female students in vocational schools in Japan , 2008, Sexually Transmitted Infections.

[36]  H. Westh,et al.  Low prevalence of the new variant of Chlamydia trachomatis in Denmark , 2008, Sexually Transmitted Infections.